In this, its first presentation to the medical community, entitled "The Efficacy and Safety of a Powered, Handheld Spinal Mobilization Instrument in the Treatment of Patients with Chronic Back Pain."

Successful patient outcomes for individuals treated with its FDA cleared medical device, the Advanced Spinal Mobilization Instrument (ASMI) were demonstrated. The study details the clinical results in patients with chronic back pain greater than three months in duration, and included reductions in pain, disability and improvements in function.

Treatment consisted of powered spinal mobilization with the ASMI two or three times per week for four weeks. Patients were examined, completed questionnaires and received range of motion and strength evaluations before beginning and again upon completion of treatment.

After one month of treatment, 11 patients (65 percent) showed improvements in walking, sitting or standing while 9 patients (53 percent) experienced reductions in pain and improvements in sleeping and social life on the Oswestry Disability Scale, a validated and commonly used measure of disability for patients with chronic conditions. In addition, 14 patients (88 percent) demonstrated some measure of pain relief and about half of all patients said their pain was more than 50 percent improved after just 1 month of treatment. Importantly, several patients demonstrated 90 percent - 100 percent relief of pain.

Jeffrey R. Perelman, MD, president of AST says, "I look forward to additional research and patient experience supporting the efficacy and success of our treatment including long term results for these patients as well as future studies demonstrating the successful use of the ASMI in a variety of settings for various conditions that result in back and neck pain."

Source: Advanced Spinal Technologies